Scott Michael Habig - Net Worth and Insider Trading

Scott Michael Habig Net Worth

The estimated net worth of Scott Michael Habig is at least $2 Million dollars as of 2024-04-29. Scott Michael Habig is the Chief Commercial Officer of Aurinia Pharmaceuticals Inc and owns about 474,587 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $2 Million. Details can be seen in Scott Michael Habig's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Michael Habig has not made any transactions after 2024-03-06 and currently still holds the listed stock(s).

Transaction Summary of Scott Michael Habig

To

Scott Michael Habig Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Michael Habig owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .

Click here to see the complete history of Scott Michael Habig’s form 4 insider trades.

Insider Ownership Summary of Scott Michael Habig

Ticker Comapny Transaction Date Type of Owner
AUPH Aurinia Pharmaceuticals Inc 2024-03-06 Chief Commercial Officer

Scott Michael Habig Latest Holdings Summary

Scott Michael Habig currently owns a total of 1 stock. Scott Michael Habig owns 474,587 shares of Aurinia Pharmaceuticals Inc (AUPH) as of March 6, 2024, with a value of $2 Million.

Latest Holdings of Scott Michael Habig

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AUPH Aurinia Pharmaceuticals Inc 2024-03-06 474,587 5.01 2,377,681

Holding Weightings of Scott Michael Habig


Scott Michael Habig Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Michael Habig has made a total of 3 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 17,777 shares on March 6, 2024, which brought Scott Michael Habig around $99,551.

Insider Trading History of Scott Michael Habig

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Michael Habig Trading Performance

GuruFocus tracks the stock performance after each of Scott Michael Habig's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Michael Habig is 65.61%. GuruFocus also compares Scott Michael Habig's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Michael Habig within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Scott Michael Habig's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Scott Michael Habig

Average Return

50.7%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.96 65.61 122.66 50.7
Relative Return to S&P 500(%) -11.92 56.73 112.77 34.73

Scott Michael Habig Ownership Network

Ownership Network List of Scott Michael Habig

No Data

Ownership Network Relation of Scott Michael Habig


Scott Michael Habig Owned Company Details

What does Aurinia Pharmaceuticals Inc do?

Who are the key executives at Aurinia Pharmaceuticals Inc?

Scott Michael Habig is the Chief Commercial Officer of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include director & Chief Executive Officer Peter Greenleaf , Chief Financial Officer Joseph M Miller , and Ex VP & Intern'l Operations Matthew Maxwell Donley .

Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary

Over the past 18 months, Scott Michael Habig made 3 insider transaction in Aurinia Pharmaceuticals Inc (AUPH) with a net sale of 28,644. Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 192,778 shares made by Peter Greenleaf , a net sale of 96,791 shares made by Stephen P. Robertson , and a net sale of 57,505 shares made by Joseph M Miller .

In summary, during the past 3 months, insiders sold 323,922 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 323,922 shares. During the past 18 months, 474,747 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 65,000 shares were bought by its insiders, resulting in a net sale of 409,747 shares.

Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aurinia Pharmaceuticals Inc Insider Transactions

No Available Data

Scott Michael Habig Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Michael Habig. You might contact Scott Michael Habig via mailing address: #1203-4464 Markham Street, Victoria A1 V8z7x8.

Discussions on Scott Michael Habig

No discussions yet.